Today in News History

On July 12, several notable moments in the history of News stand out. In 1730, Josiah Wedgwood, English potter, founded the Wedgwood Company (died 1795) was born. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1925, Roger Smith, American businessman (died 2007) was born. In 1943, Paul Silas, American basketball player and coach (died 2022) was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1959, Karl J. Friston, English psychiatrist and neuroscientist was born. In 1985, Keven Lacombe, Canadian cyclist was born. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

The Motley Fool

The Motley Fool

·

June 26, 2026

·

lean left

Bristol Myers Squibb leans on specialty medicines and a discounted valuation, while Johnson Johnson boasts industry-leading margins and cash flow.

Narrative Intelligence Brief

This article was published by The Motley Fool, a source frequently categorized with a lean left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Motley Fool, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 2 related reports from 2 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

2 sources

Left 50%

Center 0%

Right 50%


Topics:

Business · 2

Related coverage for "Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?": Seeking Alpha — Ascendis Pharma: Behind The Stock Surge. The Motley Fool — Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.